Stock CALTX CALLIDITAS THERAPEUTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Calliditas Therapeutics AB

Equities

CALTX

SE0010441584

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:42 2024-05-31 am EDT 		5-day change 1st Jan Change
208.2 SEK +0.10% Intraday chart for Calliditas Therapeutics AB +81.83% +63.81%
May. 31 Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 MT
May. 31 Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. CALTX Stock
  4. Revisions Calliditas Therapeutics AB